company logo

Below is a select list of recent significant publications on antiviral agents and novel approaches from the ReViral team.

Antivir Chem Chemother2012 Jan 17;22(4):139-50. doi: 10.3851/IMP1873.The prophylaxis and treatment with antiviral agents of respiratory syncytial virus infections. Najarro P, Angell R, Powell K.

NS5a Targeting Inhibitors.  Hepatitis C: Antiviral Drug Discovery and Development, Horizon Scientific Press.  March 2011. Pilar Najarro, Neil Mathews and Stuart Cockerill

Inhibitors of Respiratory Syncytial Virus.  Chapter 14.  Pages. 229-245.  Annual Reports in Medicinal Chemistry. Vol. 43, 2008. Elsevier. Malcolm Carter and G. Stuart Cockerill.

RSV604, a novel inhibitor of respiratory syncytial virus replicationAntimicrobial Agents and Chemotherapy  (2007),  51(9),  3346-3353.  Chapman, Joanna; Abbott, Elizabeth; Alber, Dagmar G.; Baxter, Robert C.; Bithell, Sian K.; Henderson, Elisa A.; Carter, Malcolm C.; Chambers, Phil; Chubb, Ann; Cockerill, G. Stuart; Collins, Peter L.; Dowdell, Verity C. L.; Keegan, Sally J.; Kelsey, Richard D.; Lockyer, Michael J.; Luongo, Cindy; Najarro, Pilar; Pickles, Raymond J.; Simmonds, Mark; Taylor, Debbie; Tyms, Stan; Wilson, Lara J.; Powell, Kenneth L

1,4-Benzodiazepines as Inhibitors of Respiratory Syncytial Virus.  Journal of Medicinal Chemistry, 2006, 49, 2311 – 2319.  Malcolm C. Carter, Dagmar G. Alber, Robert C. Baxter, Sian K. Bithell, Jo Budworth, Ann Chubb, G. Stuart Cockerill, Verity C. L. Dowdell, Elisa A. Henderson, Sally J. Keegan, Richard D. Kelsey, Michael J. Lockyer, Jeremy N. Stables, Lara J. Wilson, and Kenneth L. Powell.